These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22495)

  • 1. Serum-derived immunosuppressive substances. II. An evaluation of various sources for an endogenous regulator of lymphocyte activation.
    Miller F; Habicht GS
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):228-38. PubMed ID: 22495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-derived immunosuppressive substances. III. Regulation of the immune response by human serum alpha-globulin fractions: the dose-response relationship.
    Habicht GS; Miller F
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):239-46. PubMed ID: 73512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of immunoregulatory factors from normal human serum. I. Preliminary biochemical and biological characterization of immunosuppressive factors.
    Voorting-Hawking M; Michael JG
    J Immunol; 1977 Feb; 118(2):505-13. PubMed ID: 190315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further purification of the lymphocyte inhibiting extract from the thymus.
    Kiger N; Florentin I; Mathe G
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):244-9. PubMed ID: 130147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and biological properties of a thymocyte specific growth factor from calf thymus.
    Söder O; Ernström U
    Thymus; 1981 Nov; 3(4-5):289-305. PubMed ID: 6976028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of a ribonuclease-containing fraction from bacterial cultures.
    Carpenter CB; Milton JD; Mowbray JF; Butterworth AE
    Immunology; 1972 Aug; 23(2):171-82. PubMed ID: 4115966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.
    Rubin AS; Macdonald AB
    Immunology; 1976 Jan; 30(1):69-81. PubMed ID: 765266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytopoietic and radioprotective effects of a highly purified calf thymus preparation.
    Sudo T; Funakoshi S; Manita H; Dobashi K; Asano H
    Radiat Res; 1972 Apr; 50(1):136-57. PubMed ID: 5021826
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
    Parmely MJ; Thompson JS
    J Immunol; 1976 Nov; 117(5 Pt.2):1832-7. PubMed ID: 62791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).
    Kiger N; Florentin I; Lorans G; Mathe G
    Immunology; 1977 Oct; 33(4):439-48. PubMed ID: 924515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous factors possessing lymphoid chalone properties, purified by chromatography.
    Privat de Garilhe M; Vedel M; Tempête C; Federici C; Garcia-Giralt E
    Biomedicine; 1980 Oct; 32(3):148-54. PubMed ID: 6449966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of deoxyribonuclease II from sheep spleen.
    Slor H; Hodes ME
    Arch Biochem Biophys; 1970 Jul; 139(1):172-8. PubMed ID: 4319459
    [No Abstract]   [Full Text] [Related]  

  • 17. A nonspecific immunosuppressive material derived from normal bovine serum.
    Karpas AB; Segre D
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):141-7. PubMed ID: 4589210
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-specific normal immunosuppressive protein (Nip): purification and further biochemical characterization.
    Gavison-Goren R; Nelken D
    Immunology; 1983 Aug; 49(4):599-608. PubMed ID: 6192080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic suppressing factor: purification and characterization of a factor suppressing thymidine incorporation into activated lymphocytes.
    Kasahara T; Shiori-Nakano K
    J Immunol; 1976 May; 116(5):1251-6. PubMed ID: 1083867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific substances of the thymus reacting with thymus-dependant antigens].
    Bezvershenko IA; Bykova LM; Lukashova RH
    Ukr Biokhim Zh; 1975; 47(1):85-9. PubMed ID: 1202699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.